Home health remedies With the world waiting, Roche socks $459M into COVID-19 antibody test production

With the world waiting, Roche socks $459M into COVID-19 antibody test production

14
0
SHARE

Roche scored a major win with the FDA’s backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality. Now, to cover its booming production goals, Roche plans to infuse nearly half-a-billion dollars into its German manufacturing facility. 

Roche will plow $459 million into its manufacturing facility in Penzberg, Germany, to boost production of the antibody test that won an emergency use authorization from the FDA last week, Reuters reported

At a German Ethics Council meeting Monday, officials said the government had signed a deal with Roche to secure 3 million diagnostic tests in May and an additional 5 million each following month. Eventually, Roche will aim to produce nearly 100 million tests per month by the end of 2020, according to Reuters. 

Webinar

Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus

A panel of CATO SMS experts will review the key issues contained in the emerging Agency Guidance and offer thoughts on what changes and options for sponsors may be seen in the coming months.

Roche is reportedly also working on a four-year plan to develop a brand-new research and diagnostic center. 

After the FDA approval Friday, Roche said it is prepared to produce “high double-digit millions” of the tests in May with the intent to continue ramping up production. 

RELATED: COVID-19 antibody testing ‘a disaster,’ says Roche CEO, as diagnostics sales rise

Roche began testing its antibody diagnostic, which runs on its high-throughput Elecsys assay platform and cobas line of analyzers, in mid-April.

During a first-quarter earnings call with analysts late last month, Roche CEO Severin Schwan blasted the current state of COVID-19 serology tests, calling many of the diagnostics “amateur.”

“These tests are not worth anything, or have very little use,” Schwan said at the time. “Some of these companies, I tell you, this is ethically very questionable to get out with this stuff.” 

RELATED: FDA grants Roche coronavirus test emergency green light within 24 hours

Roche has not only scored an emergency use nod for antibody tests but also for a fully automated molecular test for active COVID-19 patients. 

The FDA authorized Roche’s diagnostic test in mid-March, just 24 hours after receiving the application. Previously, the FDA had only allowed specific, certified laboratories to use their preapproved and validated diagnostics in identifying COVID-19 patients.

Now, this latest Emergency Use Authorization enables clinicians to run the Roche test on the company’s cobas 6800/8800 molecular testing systems, widely available at hospitals and labs throughout the country. It is also available in European countries accepting the CE mark.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

nineteen + nineteen =